Takeda Pharmaceutical Company Limited Increase Decrease In Existing Provisions Other Provisions
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease In Existing Provisions Other Provisions of JPY 960.05 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInExistingProvisionsOtherProvisions · last filed 2025-06-25
| Period end | Increase Decrease In Existing Provisions Other Provisions 12 month | Increase Decrease In Existing Provisions Other Provisions 12 month as first filed |
|---|---|---|
| 2025-03-31 | 960.05B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 1.04T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 1.06T JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 900.35B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 914.01B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 882.07B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 495.32B JPY 20-F · filed 2020-06-24 | 495.31B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 333.71B JPY 20-F · filed 2019-06-27 |